CHGCF
Price
$41.68
Change
-$1.51 (-3.50%)
Updated
Sep 25 closing price
Capitalization
73.57B
CHGCY
Price
$21.89
Change
-$0.73 (-3.23%)
Updated
Sep 25 closing price
Capitalization
73.57B
Interact to see
Advertisement

CHGCF vs CHGCY

Header iconCHGCF vs CHGCY Comparison
Open Charts CHGCF vs CHGCYBanner chart's image
Chugai Pharmaceutical
Price$41.68
Change-$1.51 (-3.50%)
Volume$2.34K
Capitalization73.57B
Chugai Pharmaceutical
Price$21.89
Change-$0.73 (-3.23%)
Volume$369.35K
Capitalization73.57B
CHGCF vs CHGCY Comparison Chart in %
Loading...
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHGCF vs. CHGCY commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHGCF is a Hold and CHGCY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CHGCF: $41.68 vs. CHGCY: $21.89)
Brand notoriety: CHGCF and CHGCY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: CHGCF: 86% vs. CHGCY: 217%
Market capitalization -- CHGCF: $73.57B vs. CHGCY: $73.57B
CHGCF [@Pharmaceuticals: Major] is valued at $73.57B. CHGCY’s [@Pharmaceuticals: Major] market capitalization is $73.57B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $640.6B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHGCF’s FA Score shows that 0 FA rating(s) are green whileCHGCY’s FA Score has 1 green FA rating(s).

  • CHGCF’s FA Score: 0 green, 5 red.
  • CHGCY’s FA Score: 1 green, 4 red.
According to our system of comparison, both CHGCF and CHGCY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHGCF’s TA Score shows that 2 TA indicator(s) are bullish while CHGCY’s TA Score has 4 bullish TA indicator(s).

  • CHGCF’s TA Score: 2 bullish, 7 bearish.
  • CHGCY’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CHGCY is a better buy in the short-term than CHGCF.

Price Growth

CHGCF (@Pharmaceuticals: Major) experienced а -12.55% price change this week, while CHGCY (@Pharmaceuticals: Major) price change was -5.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.02%. For the same industry, the average monthly price growth was -0.27%, and the average quarterly price growth was +12.71%.

Industries' Descriptions

@Pharmaceuticals: Major (-1.02% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHGCF($73.6B) and CHGCY($73.6B) have the same market capitalization . CHGCY (26.90) and CHGCF (25.61) have similar P/E ratio . CHGCF YTD gains are higher at: -0.120 vs. CHGCY (-0.364). CHGCF (556B) and CHGCY (556B) have comparable annual earnings (EBITDA) . CHGCF (1.03T) and CHGCY (1.03T) have equal amount of cash in the bank . CHGCF (1.2T) and CHGCY (1.2T) have equivalent revenues.
CHGCFCHGCYCHGCF / CHGCY
Capitalization73.6B73.6B100%
EBITDA556B556B100%
Gain YTD-0.120-0.36433%
P/E Ratio25.6126.9095%
Revenue1.2T1.2T100%
Total Cash1.03T1.03T100%
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CHGCF vs CHGCY: Fundamental Ratings
CHGCF
CHGCY
OUTLOOK RATING
1..100
2112
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
25
Undervalued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6159
P/E GROWTH RATING
1..100
7268
SEASONALITY SCORE
1..100
8543

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHGCY's Valuation (25) in the null industry is in the same range as CHGCF (35). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.

CHGCY's Profit vs Risk Rating (97) in the null industry is in the same range as CHGCF (100). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.

CHGCY's SMR Rating (99) in the null industry is in the same range as CHGCF (99). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.

CHGCY's Price Growth Rating (59) in the null industry is in the same range as CHGCF (61). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.

CHGCY's P/E Growth Rating (68) in the null industry is in the same range as CHGCF (72). This means that CHGCY’s stock grew similarly to CHGCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHGCFCHGCY
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
32%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 8 days ago
56%
Bullish Trend 8 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
CHGCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LITB2.090.06
+2.96%
LightInTheBox Holding Co Ltd
LEGN32.82-0.06
-0.18%
Legend Biotech Corp
FSTR26.71-0.15
-0.56%
L.B. Foster Company
KLAC1059.10-9.57
-0.90%
KLA Corp
XERS7.85-0.15
-1.88%
Xeris Biopharma Holdings

CHGCF and

Correlation & Price change

A.I.dvisor tells us that CHGCF and CHGCY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCF and CHGCY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCF
1D Price
Change %
CHGCF100%
-3.50%
CHGCY - CHGCF
32%
Poorly correlated
-3.23%
CMOPF - CHGCF
10%
Poorly correlated
N/A
DSKYF - CHGCF
-2%
Poorly correlated
-2.30%
CHJTF - CHGCF
-3%
Poorly correlated
-0.83%
DSNKY - CHGCF
-5%
Poorly correlated
-1.09%
More

CHGCY and

Correlation & Price change

A.I.dvisor tells us that CHGCY and CHGCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCY and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
-3.23%
CHGCF - CHGCY
32%
Poorly correlated
-3.50%
OTSKY - CHGCY
30%
Poorly correlated
-1.99%
OPHLY - CHGCY
22%
Poorly correlated
-1.58%
DSNKY - CHGCY
22%
Poorly correlated
-1.09%
RHHBY - CHGCY
20%
Poorly correlated
-2.68%
More